Earn 43 points upon purchasing this product.

SKU: N/A Categories: ,


Myostatin Vials

CAS Number 118732224
Molar Mass 2956.5g.mol-1
Chemical Formula C133H227N43O33
IUPAC Name  D-leucyl-D-arginyl-2-cyclohexyl-D-glycyl-D-lysyl-D-arginyl-D-tryptophyl-D-isoleucyl-D-arginyl-2-cyclohexyl-D-glycyl-D-lysyl-D-isoleucyl-D-tryptophyl-D-arginyl-D-isoleucyl-D-tyrosyl-D-tryptophanamide


Myostatin represent an advanced research tool meticulously crafted for the investigation of Myostatin’s role in diverse biological processes. Myostatin, also identified as growth and differentiation factor 8 (GDF-8), is a key member of the transforming growth factor-beta (TGF-β) superfamily. It plays a pivotal role in regulating skeletal muscle development and growth by inhibiting myoblast proliferation and differentiation. The utilization of our high-quality Myostatin peptide vials empowers researchers to delve into the intricate mechanisms underlying Myostatin activity, offering a platform to explore potential therapeutic implications associated with the modulation of Myostatin.

Key Characteristics

These Myostatin Vials contain a high-quality Myostatin inhibitor, designed with precision for laboratory use. The formulation ensures consistency and purity, providing researchers with a reliable resource for their investigations into Myostatin modulation.

Research Applications

Tailored for laboratory applications, Myostatin Vials serve as a crucial asset for researchers exploring the multifaceted functions of Myostatin. This research product finds applications in diverse scientific domains, offering a platform to investigate Myostatin’s influence on specific physiological processes.

Research Benefits

Myostatin Inhibition and Duchenne Muscular Dystrophy

Research studies have suggested that inhibiting Myostatin could potentially offer therapeutic benefits in the context of Duchenne Muscular Dystrophy (DMD). By exploring the modulation of Myostatin, researchers aim to contribute to the understanding of mechanisms that may mitigate the effects of this debilitating muscular disorder.

Myostatin Inhibition and Cancer Cachexia

Studies indicate a connection between Myostatin inhibition and its potential role in addressing cancer cachexia, a complex syndrome characterized by muscle wasting. Researchers employing Myostatin Vials seek to unravel the underlying mechanisms, providing insights into potential interventions for managing muscle loss associated with cancer.

Myostatin Inhibition and Muscle Growth

The inhibition of Myostatin has been associated with enhanced muscle growth. Researchers aim to delve into the mechanisms underlying this phenomenon, exploring the potential implications for muscle development and regeneration.


In summary, Myostatin Vials serve as a dedicated research tool, facilitating investigations into the diverse biological roles of Myostatin. With documented benefits in addressing Duchenne Muscular Dystrophy, cancer cachexia, and promoting muscle growth, this research product offers valuable insights into the potential therapeutic applications of Myostatin modulation. It is crucial to emphasize that these Myostatin Vials are strictly for research purposes, and any discussion related to human consumption is outside the scope of this research-oriented offering.


  1. Gutierrez-Salmean G, Ciaraldi TP, Nogueira L, Barboza J, Taub PR, Hogan MC, Henry RR, Meaney E, Villarreal F, Ceballos G, Ramirez-Sanchez I. Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation. J Nutr Biochem. 2014 Jan;25(1):91-4. doi: 10.1016/j.jnutbio.2013.09.007. Epub 2013 Oct 18. PMID: 24314870; PMCID: PMC3857584. [Read More]
  2. Bish LT, Sleeper MM, Forbes SC, Morine KJ, Reynolds C, Singletary GE, Trafny D, Pham J, Bogan J, Kornegay JN, Vandenborne K, Walter GA, Sweeney HL. Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther. 2011 Dec;22(12):1499-509. doi: 10.1089/hum.2011.102. Epub 2011 Aug 30. PMID: 21787232; PMCID: PMC3237695. [Read More]
  3. von Haehling S, Anker SD. Prevalence, incidence, and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):261-3. doi: 10.1007/s13539-014-0164-8. PMID: 25384990; PMCID: PMC4248411. [Read More]


There are no reviews yet.

Earn 10 points by reviewing this product.
Be the first to review “Myostatin”

Your email address will not be published. Required fields are marked *